Pediatrix Medical price target raised to $15 from $13 at Mizuho

Mizuho analyst Ann Hynes raised the firm’s price target on Pediatrix Medical (MD) to $15 from $13 and keeps a Neutral rating on the shares following the “solid” Q3 report.